This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

AtriCure, RAM Energy: Volume Movers

NEW YORK ( TheStreet) -- AtriCure (ATRC - Get Report) was one of several stocks trading near $5 poised to move on above-average volume Tuesday after the company's heart device received regulatory clearance in the U.S.

AtriCure said the Food and Drug Administration gave clearance to its AtriClip system, which is designed to be implanted from the outside of the heart, avoiding contact with circulating blood and eliminating blood flow between the left atrial appendage and the atria.

AtriCure said the initial launch of the AtriClip system in the U.S. is expected to begin later this month with full commercial release planned during the third quarter of 2010.

AtriCure shares jumped by 92 cents, or 17.6%, to $6.15 in the premarket session. The 50-day average daily volume for AtriCure is 27,000, according to the Nasdaq.

Elsewhere, Synergetics USA (SURG - Get Report) rose by 18 cents, or 6.6%, to $2.91 in the premarket session after the medical device company posted third-quarter earnings of 13 cents a share, which is up from a profit of 3 cents a share in the year-ago period. The 50-day average daily volume for Synergetics is 135,000.

More on Biotech
14 Biotech Stocks Facing FDA Approval

On the downside, Trubion Pharmaceuticals (TRBN) dropped by 41 cents, or 11.2%, to $3.25 in the premarket session after Pfizer (PFE - Get Report) decided to discontinue development of TRU-015, a rheumatoid arthritis drug developed as part of a collaboration. The decision came as the drug failed to meet its goal in a mid-stage clinical trial.

Pfizer did confirm that it would continue to develop SBI-087, a different rheumatoid arthritis drug candidate also in Phase 2 clinical evaluation. The 50-day average daily volume for Trubion is 22,000.

RAM Energy (RAM) shares will likely see an increase in trading volume after the company said management has been authorized to review strategic alternatives for the company, including a sale, refinancing or recapitalization. RAM Energy shares closed Monday at $1.77, and the 50-day average daily volume for RAM is 189,000.

Meanwhile, Bakers Footwear (BKRS) should also see a bump in trading volume after the company said it has not achieved the minimum level of shareholders' equity required for continued listing on the Nasdaq Capital Mark, and it expects to be delisted as soon as this week. Bakers said it is working with market makers to have its stock listed on the OTC Bulletin Board or the Pink Sheets.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
ATRC $17.40 -0.40%
PFE $34.64 0.23%
SURG $4.63 0.43%
AAPL $128.54 -0.63%
FB $80.90 1.63%


DOW 18,096.90 -106.47 -0.58%
S&P 500 2,098.53 -9.25 -0.44%
NASDAQ 4,967.1410 -12.76 -0.26%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs